FDA Summary FAERS Report for WINREVAIR (sotatercept) for PAH Indication

FDA Summary FAERS Report for WINREVAIR (sotatercept) for PAH Indication

Regular price $69.00 USD
Regular price Sale price $69.00 USD
Sale Sold out
Original Request: A summary FAERS report for the product WINREVAIR (sotatercept) for its indication in PAH.
Tags: Pharma, FAERS, 2025
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. IMPORTANT: The FDA FOIA office operations are currently suspended. We are happy to make the request but do not know when we will receive a response. Learn more about Fast-Track Requests here.

View full details